Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: Previous studies show that transgender and gender-diverse (TGD) individuals, especially those assigned male at birth (AMAB), often have low bone mineral density (BMD) before beginning gender-affirming hormone therapy (GAHT). The reasons for this are not fully understood, and the potential role of androgen receptor (AR) polymorphisms - known to affect bone density in the general population - has not been explored. This study aims to assess the impact of AR polymorphisms on bone health in the TGD population.
Methods: This is an observational study involving 135 TGD and 107 cisgender participants. Collected data included hormonal profiles and phospho-calcium metabolism, bone geometry and density (Dual Energy X-ray Absorptiometry and peripheral Quantitative Computed Tomography). For the genetic study related to the AR, genomic DNA was extracted from peripheral blood leukocytes.
Results: TGD individuals had lower BMD values compared to their cisgender peers. In a subgroup of 129 individuals (86 TGD and 43 cisgender), we assessed the length of the polymorphic tracts of the AR gene and observed no differences between the groups. AR polymorphisms showed significant correlations only with cortical BMD in both TGD and cisgender assigned females at birth (AFAB) individuals, and negative correlations with trabecular BMD in both cisgender men and women.
Conclusions: Our study suggests that AR polymorphisms do not play a significant role in the low BMD values observed in TGD individuals at baseline. Further research is necessary to better understand the impact of factors such as lifestyle on the bone health of TGD individuals.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s40618-024-02522-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Gender-Affirming Care and Gynecology: Best Practices for Supporting Youth Who Are Transgender and Gender Diverse.
Pediatr Ann
September 2025
Division of Gynecology, Boston Children's Hospital, Department of Surgery, Harvard Medical School.
Based on extensive evidence, gender-affirming care (GAC) is endorsed by numerous medical societies as the gold standard for supporting youth who are transgender and gender diverse (TGD). Unfortunately, there remain barriers to accessing GAC and an ongoing risk of gender identity-based mistreatment for youth who are TGD accessing all forms of health care. Gynecologic care is commonly accessed by youth who are TGD as part of medical gender affirmation, with needs ranging from hormone management, menstrual suppression, contraception counseling, and surgical consultation.
View Article and Find Full Text PDFBackground: To help reduce mental health disparities in the transgender and gender diverse (TGD) population, there is a need to equip future psychiatric mental health nurse practitioners (PMHNPs) with affirming care competence.
Method: This study evaluated a multimodal education program that combined eLearning with two virtual standardized patient (SP) simulations to teach PMHNP students to provide affirming mental health care to TGD people.
Results: Slight increases in knowledge and attitudes were not practically applicable.
Non-Sedated Intrauterine Device Experiences Among Transgender and Cisgender Adolescents and Young Adults in the Outpatient Setting.
J Pediatr Adolesc Gynecol
September 2025
Division of Adolescent Medicine, Seattle Children's Hospital, Seattle, WA, USA.
Study Objectives: This study compares the demographic characteristics and experiences of three different groups of adolescent and young adults (AYAs) seeking non-sedated intrauterine device (IUD) insertion in the outpatient setting: (1) cisgender individuals, (2) transgender and gender diverse (TGD) individuals receiving gender-affirming testosterone therapy, and (3) TGD individuals not receiving gender-affirming testosterone therapy.
Methods: This retrospective cohort study included AYAs age 13 to 21 years seeking IUD insertion. Data were obtained from the electronic health record via a pre-existing, multi-institutional shared quality improvement (QI) collaborative.
The Experiences of Transgender and Gender Diverse Individuals After Intonation Training for a More Masculine-Sounding Voice: A Qualitative Study.
J Voice
September 2025
Center for Speech and Language Sciences (CESLAS), Department of Rehabilitation Sciences, Ghent University, Ghent, Belgium; Department of Otorhinolaryngology and Head and Neck Surgery, Ghent University Hospital, Ghent, Belgium.
Introduction: A significant challenge for some transgender and gender diverse (TGD) individuals is that their voice and communication do not align with their gender identity or the way they wish to be perceived. Voice and communication training (VCT) can address key factors that are the most salient in gender perception, such as pitch, resonance, articulation, and intonation. While intonation training has proven its benefits for developing a feminine-sounding voice, its impact on achieving a masculine-sounding voice remains underexplored.
View Article and Find Full Text PDFKidney Health and Gender-Affirming Hormone Therapy for Transgender and Gender Diverse Individuals.
Clin J Am Soc Nephrol
September 2025
VA Greater Los Angeles Health Care System, Department of General Internal Medicine, Department of Medicine.
This review examines the effects of gender-affirming hormone therapy (GAHT) on kidney health in transgender and gender diverse (TGD) populations, which face significant challenges in accessing medical care. GAHT, typically involves estrogen therapy for transgender women and transfeminine individuals, testosterone therapy for transgender men and transmasculine individuals, and therapy regimens for individuals who are nonbinary or identify with another gender not culturally assigned to their sex assigned at birth. Hormone therapy influences biomarkers such as creatinine and cystatin C, which are used in estimating glomerular filtration rate (eGFR).
View Article and Find Full Text PDF